Here’s What the Street Thinks About The Cigna Group (CI) Post Earnings

The Cigna Group (NYSE:CI) is one of the best strong buy healthcare stocks to invest in. On February 17, Truist lifted the price target on The Cigna Group (NYSE:CI) to $350 from $320 while maintaining a Buy rating on the shares, and telling investors that it is adjusting its model following the company’s release of its fiscal Q4 financial results and 2026 guidance. Deutsche Bank also raised the price target on The Cigna Group (NYSE:CI) to $304 from $301 on February 10 and maintained a Buy rating on the shares. It stated that it views the company’s fiscal year 2026 guidance and the FTC deal as possibly a clearing event.

The Cigna Group (NYSE:CI) also received a rating update from TD Cowen on February 9, with the firm lifting the price target on the stock to $338 from $333 while maintaining a Buy rating on the shares following the company’s fiscal Q4 results and FY26 guidance. The firm believes that fiscal Q4 represented a meaningful catalyst for shares, as it removes two key overhangs over the past two years: stop loss and PBM reform.

The Cigna Group (NYSE:CI) provides global health services and operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.